Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Lupin Limited
Press Release Dec 27 2023
Business
Dec 27 2023
5 min read

Press Release Dec 27 2023

Lupin Limited has informed the Exchange regarding a press release dated December 27, 2023, titled "Lupin Receives Approval from U.S. FDA for Loteprednol EtabonateOphthalmic Suspension, 0.2%.".

View Attachment